Northera (Lundbeck Pharmaceuticals LLC)


Welcome to the PulseAid listing for the Northera drug offered from Lundbeck Pharmaceuticals LLC. This Catecholamines [Chemical/Ingredient],Increased Blood Pressure [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Lundbeck Pharmaceuticals LLC
NON-PROPRIETARY NAME: droxidopa
SUBSTANCE NAME: DROXIDOPA
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Catecholamines [Chemical/Ingredient],Increased Blood Pressure [PE]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2014-09-01
END MARKETING DATE: 0000-00-00


Northera HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNorthera from Lundbeck Pharmaceuticals LLC
LABELER NAME: Lundbeck Pharmaceuticals LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/1)
START MARKETING DATE: 2014-09-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 67386-820_ccb12992-471d-4622-bb31-4fe70a08d4ec
PRODUCT NDC: 67386-820
APPLICATION NUMBER: NDA203202

Other DROXIDOPA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Lundbeck Pharmaceuticals LLCNorthera